AMN Healthcare Services, Inc.

NYSE:AMN

Medical - Care Facilities

Healthcare
$37.60 -3.98%

-$1.29 today

Market cap
$1.45B
Beta
0.44
P/E (TTM)
-37.3
EPS (TTM)
-$0.83
52W Low $14.87High $33.13

Volume 0.55M

Average 1.02M

AMN Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

AMN Healthcare Services, Inc.NYSE: AMN

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses growth accelerates

Q1 FY2026 operating expenses of $251.67M rose 35.6% year over year, ahead of the -1.3% change in trailing-twelve-month operating expenses. Sequentially, it rose 34.6% from the prior quarter. Over 3 fiscal years it compounded at -11.5% a year.

Context

  • Operating expenses amounted to 27.1% of revenue in FY2025, down 7.1 pp from a year earlier.
  • Operating expenses increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +35.6% holds above the trailing-twelve-month pace of -1.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$251.67M+34.6% QoQ
Last fiscal yearDec 2025
$740.89M-27.5% YoY
LTMMar 2026
$934.72M-1.3% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+35.6%——
1 year-27.5%——
3-year CAGR-11.5%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
740.89M USD
Year-over-year change
-27.5%
4-year CAGR
-2.8%

Operating Expenses vs competitors

How AMN compares with its peers on the latest reported figures

  • AMN's LTM Mar 2026 operating expenses of $934.72M is the 2nd highest of the 11 companies compared; the peer median is $175.59M.
  • Its year-over-year change of -1.3% is the 6th highest of 11, against a peer median of -3.0%.
  • Operating expenses amounts to 27.3% of revenue for AMN, versus a peer median of 62.7%.
AMN Competitors Peer median
Operating Expenses for AMN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MYGNMyriad Genetics, Inc.LTM Mar 2026$963.5M +36.4%+1.5%116.2%
AMNAMN Healthcare Services, Inc.LTM Mar 2026$934.72M -1.3%-11.5%27.3%
DNAGinkgo Bioworks Holdings, Inc.LTM Mar 2026$403.62M -39.1%-43.2%285.6%
REPLReplimune Group, Inc.LTM Dec 2025$325.61M +35.1%+30.8%—
EVHEvolent Health, Inc.LTM Mar 2026$283.23M -28.2%-2.7%15.0%
HSTMHealthStream, Inc.LTM Mar 2026$178.93M +3.1%+2.7%57.4%
CMPSCOMPASS Pathways plcLTM Mar 2026$172.25M -9.0%+17.5%—
NUTXNutex Health, Inc.LTM Mar 2026$141.44M +37.2%-26.3%16.1%
BFLYButterfly Network, Inc.LTM Mar 2026$132.08M +8.1%-17.2%128.3%
AIRSAirSculpt Technologies, Inc.LTM Mar 2026$103.33M -16.8%-6.2%68.1%
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026-$23.84M -106.2%-34.0%11.4%
Peer median (excluding AMN) $175.59M-3.0%-4.4%62.7%

Competitors are the stored peer set for AMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.98B5.24B3.79B2.98B2.73B
Cost of Revenue2.67B3.53B2.54B2.06B1.96B
Gross Profit1.31B1.72B1.25B919.38M774.06M
Gross Margin32.9%32.7%33.0%30.8%28.3%
Research & Development00000
Selling, General & Admin730.45M936.58M756.24M632.49M593.02M
Operating Expenses831.6M1.07B911.15M1.02B740.89M
Depreciation & Amortization103.7M137.11M160.93M173.78M156.6M
EBITDA581.7M784.21M499.36M71.11M101.13M
EBITDA Margin14.6%15.0%13.2%2.4%3.7%
Operating Income478M647.1M338.43M(102.67M)33.17M
Operating Margin12.0%12.3%8.9%-3.4%1.2%
Interest Income00000
Interest Expense34.08M40.4M54.14M69.9M45.59M
Other Income / Expenses(34.08M)(40.4M)(54.14M)(69.9M)(134.23M)
Income Before Tax443.92M606.7M284.29M(172.57M)(101.06M)
Pre-Tax Margin11.1%11.6%7.5%-5.8%-3.7%
Income Tax Expense116.53M162.65M73.61M(25.6M)(5.36M)
Net Income327.39M444.05M210.68M(146.98M)(95.7M)
Net Margin8.2%8.5%5.6%-4.9%-3.5%
EPS (Basic)6.879.965.38(3.85)(2.48)
EPS (Diluted)6.819.905.36(3.85)(2.48)
Weighted Avg Shares47.69M44.59M39.17M38.19M38.52M
Weighted Avg Shares (Diluted)48.05M44.87M39.34M38.19M38.52M

AMN Healthcare Services, Inc.

NYSE:AMN

Intrinsic Alpha fair value

Locked

Current Price

$37.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.